Contents

Search

hydroquinone (Melanex, Musely, Eldopaque-Forte, Eldoquine-Forte, Solaquin-Forte)

Tradenames: Melanex, Eldopaque-Forte, Eldoquine-Forte, Solaquin-Forte. Indications: - dyschromia, melasma [5] - gradual bleaching of hyperpigmented skin conditions Contraindications: Caution: use sunscreen & protective clothing Dosage: Hyperpigmentation: apply BID. Cream: (Eldopaque-Forte, Solaquin-Forte) 4% (30 g) Gel: (Solaquin-Forte): 4% (30 g) Solution: (Melanex) 3% (30 g) Adverse effects: - not common (1-10%) - dermatitis, dryness, erythema, stinging, irritation, inflammatory reaction, sensitization, ochronosis

General

dermatologic agent

Properties

MISC-INFO: pregnancy-category C safety in lactation ?

Database Correlations

PUBCHEM cid=785

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. Department of Veterans Affairs, VA National Formulary
  4. Prescriber's Letter 13(10): 2006 FDA's Proposed Ban of Over-The-Counter Skin Bleaching Products Detail-Document#: 221010 (subscription needed) http://www.prescribersletter.com
  5. Deprecated Reference

Component-of

all trans retinoic acid/fluocinolone/hydroquinone all trans retinoic acid/fluticasone/hydroquinone hydroquinone/lanolin